Entries by BioSpace

,

Two Sugary Drinks A Day Can Raise Liver Disease Risk, Tufts University Study

Daily Sugar-Sweetened Beverage Habit Linked To Non-Alcoholic Fatty Liver Disease BOSTON (June 5, 2015) – A daily sugar-sweetened beverage habit may increase the risk for non-alcoholic fatty liver disease (NAFLD), researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HRNCA) at Tufts University report today in the Journal of Hepatology. The […]

Highest Paid CEOs In Pharma

The pharmaceuticals industry is often one of the most sought-after investments for income investors, primarily because of the lofty dividend yields that can often be found among the couple of dozen companies that make up the industry. Of the 13 Big Pharma giants with a market valuation of $50 billion or more at the end […]

Former Sanofi Exec and Protoge to Join Alnylam as Senior VP

June 8, 2015By Mark Terry, BioSpace.com Breaking News Staff Cambridge, Mass.-based Alnylam Pharmaceuticals (ALNY) announced today that former Sanofi (SNY) chief strategy officer and executive vice president, David-Alexandre “DA” Gros, will join the company as senior vice president and chief business officer. At Sanofi, Gros’s duties included overseeing the French company’s partnerships. Notably, in the […]

, , ,

FDA Shuts Down NIH Pharma Lab After Finding Contamination

WASHINGTON – The National Institutes of Health Clinical Center suspended operations of its Pharmaceutical Development Section after two vials of vials of albumin, used for the administration of the drug interleukin in experimental studies, were found to have fungal contamination, the federal agency said Thursday afternoon.   In April, two vials made from the same […]

,

U.S. Man Has First Skull And Scalp Transplant

The first skull and scalp transplant has been performed in a 15-hour operation, say doctors in the US. James Boysen, who is 55 and from Texas, was missing the whole of the crown of his head after treatment for a rare type of cancer. He was also given a new kidney and pancreas during the […]

, , , , ,

Tiny Parion Sciences Wrangles Lung Pact Worth $1.2 Billion With Vertex

June 5, 2015By Riley McDermid, BioSpace.com Breaking News Sr. Editor Boston-based Vertex Pharmaceuticals (VRTX) has added another weapon to its arsenal of cystic fibrosis fighting drugs, announcing Friday it $80 million for the rights to two promising drugs from tiny Durham, N.C. biotech Parion Sciences. The drugs, dubbed P-1037 and P-1055, are epithelial sodium channel […]

, ,

Eli Lilly Commits 780,000 Additional Vials Of Insulin To Life For A Child

INDIANAPOLIS, June 4, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) has committed another 780,000 vials of insulin to the International Diabetes Federation’s Life for a Child program. Life for a Child provides free, life-saving medicine to children living in impoverished communities who otherwise would not have access to the insulin they need. The International […]